Clinuvel Pharmaceuticals Limited (CUVL)
NASDAQ: CUVL · Real-Time Price · USD
6.03
+0.37 (6.54%)
At close: Oct 2, 2026, 4:00 PM EDT
5.62
-0.41 (-6.80%)
After-hours: Oct 2, 2026, 4:44 PM EDT
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of $283.89 million as of October 2, 2026.
Market Cap
283.89M
Enterprise Value
110.06M
1-Year Change
n/a
Ranking
Category
Stock Price
$6.03
ChartMarket Cap Chart
Since July 20, 2026, Clinuvel Pharmaceuticals's market cap has decreased from $371.50M to $283.89M, a decrease of -23.58%. That is a compound annual growth rate of -73.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 284.10M | -5.05% |
| Sep 30, 2026 | 299.20M | 1.53% |
| Sep 29, 2026 | 294.70M | 2.08% |
| Sep 28, 2026 | 288.70M | 2.16% |
| Sep 25, 2026 | 282.60M | -2.62% |
| Sep 24, 2026 | 290.20M | -0.17% |
| Sep 23, 2026 | 290.70M | -0.17% |
| Sep 22, 2026 | 291.20M | - |
| Sep 21, 2026 | 291.20M | -1.69% |
| Sep 18, 2026 | 296.20M | 0.68% |
| Sep 17, 2026 | 294.20M | -0.68% |
| Sep 16, 2026 | 296.20M | - |
| Sep 15, 2026 | 296.20M | 0.51% |
| Sep 14, 2026 | 294.70M | -1.34% |
| Sep 11, 2026 | 298.70M | 1.19% |
| Sep 10, 2026 | 295.20M | -0.84% |
| Sep 9, 2026 | 297.70M | -1.33% |
| Sep 8, 2026 | 301.70M | -7.82% |
| Sep 4, 2026 | 327.30M | 3.81% |
| Sep 3, 2026 | 315.30M | 1.32% |
| Sep 2, 2026 | 311.20M | -0.67% |
| Sep 1, 2026 | 313.30M | 4.89% |
| Aug 31, 2026 | 298.70M | -3.40% |
| Aug 28, 2026 | 309.20M | -9.03% |
| Aug 27, 2026 | 339.90M | -11.37% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 300.22M |
| Evommune | 299.77M |
| Vanda Pharmaceuticals | 296.87M |
| Rocket Pharmaceuticals | 288.71M |
| Upstream Bio | 288.64M |
| SAB Biotherapeutics | 288.43M |
| X4 Pharmaceuticals | 287.53M |
| Fate Therapeutics | 283.97M |